For decades, Viscum album—commonly known as mistletoe—has attracted attention in oncology research for its potential role as a complementary therapy in cancer care. Derived from the European mistletoe plant, Viscum album extract has been widely studied, particularly in Germany and Switzerland, where integrative medicine plays a significant role in patient care.
ABNOBA viscum album, produced by ABNOBA GmbH, is one of the most extensively researched mistletoe preparations used in integrative oncology worldwide.
Understanding Viscum Album Extract
Viscum album extract contains biologically active compounds such as lectins, viscotoxins, flavonoids, and polysaccharides, which are believed to support the immune system and improve overall well-being. These compounds may help inhibit tumor growth, enhance the body’s natural defenses, and reduce side effects associated with chemotherapy and radiotherapy.
Key Scientific Studies and Clinical Evidence
-
Improved Quality of Life and Symptom Relief
Numerous clinical trials have demonstrated that Viscum album extract improves the quality of life in cancer patients by reducing fatigue, nausea, and pain during chemotherapy.-
A 2019 meta-analysis published in BMC Complementary and Alternative Medicine reported that patients treated with mistletoe extract showed significant improvements in well-being and emotional stability.
-
-
Immunomodulatory Effects
Research shows that mistletoe lectins stimulate immune activity by increasing natural killer (NK) cell function and modulating cytokine production, helping the body recognize and target cancer cells more effectively. -
Tumor Growth Inhibition
Preclinical studies have revealed that Viscum album extracts can induce apoptosis (programmed cell death) in cancer cells and inhibit angiogenesis—the process by which tumors form new blood vessels for growth. -
Combination with Conventional Cancer Treatments
Studies involving ABNOBA viscum album in conjunction with chemotherapy or radiation therapy suggest that mistletoe therapy may reduce treatment-related toxicity and enhance tolerance, allowing patients to complete therapy cycles more comfortably. -
Survival Benefits in Certain Cancer Types
Observational studies and clinical data indicate potential survival benefits for patients with breast, lung, and pancreatic cancers who received mistletoe therapy alongside conventional treatment.
Ongoing Research and Future Prospects
Current research continues to focus on identifying the precise mechanisms of Viscum album extracts, standardizing dosages, and evaluating long-term outcomes in cancer care. ABNOBA GmbH remains at the forefront of clinical and pharmacological studies to ensure high-quality, evidence-based formulations like ABNOBA viscum album.
Conclusion
The growing body of scientific research supports the role of Viscum album extract as a valuable adjunct in integrative cancer therapy. While it is not a cure, mistletoe extract—particularly ABNOBA viscum album—offers hope and holistic support by enhancing patient resilience, improving quality of life, and potentially contributing to better treatment outcomes.
To learn more about ongoing mistletoe clinical studies and ABNOBA viscum album therapy, visit www.abnobaindia.com
